Kestra Medical Technologies, Ltd.
KMTS
$27.90
-$0.45-1.59%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 59.03% | 59.06% | 62.06% | 85.20% | 115.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.03% | 59.06% | 62.06% | 85.20% | 115.05% |
| Cost of Revenue | 29.93% | 23.79% | 18.76% | 23.76% | 29.70% |
| Gross Profit | 101.83% | 127.07% | 179.96% | 422.89% | 6,587.85% |
| SG&A Expenses | 42.79% | 100.46% | 93.25% | 80.52% | 64.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.31% | 73.34% | 64.70% | 56.65% | 47.23% |
| Operating Income | -26.66% | -82.91% | -66.25% | -44.03% | -25.06% |
| Income Before Tax | -15.52% | -69.08% | -54.75% | -33.40% | -20.81% |
| Income Tax Expenses | 117.78% | 3,300.00% | 9,250.00% | 1,188.00% | 462.50% |
| Earnings from Continuing Operations | -15.64% | -69.31% | -54.96% | -33.56% | -20.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -200.00% | -200.00% | -200.00% | -- |
| Net Income | -15.64% | -72.32% | -57.06% | -34.72% | -20.92% |
| EBIT | -26.66% | -82.91% | -66.25% | -44.03% | -25.06% |
| EBITDA | -28.07% | -96.56% | -81.75% | -57.08% | -33.89% |
| EPS Basic | 58.35% | 16.24% | 1.46% | 97.96% | 98.85% |
| Normalized Basic EPS | 53.66% | 5.37% | -5.54% | 97.92% | 98.84% |
| EPS Diluted | 58.35% | 16.24% | 1.46% | 97.96% | 98.85% |
| Normalized Diluted EPS | 53.66% | 5.37% | -5.54% | 97.92% | 98.84% |
| Average Basic Shares Outstanding | 157.29% | 130.21% | 85.00% | 93.53% | 110.69% |
| Average Diluted Shares Outstanding | 157.29% | 130.21% | 85.00% | 93.53% | 110.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |